Patients with severe haemophilia have a tendency towards recurrent haemarthroses resulting in chronic synovitis and leading to end stage
Background Recurrent haemarthroses in patients with haemophilia commonly affect the ankles. It can result in
Purpose of study:. Total elbow replacement (TER) is one of the surgical options for treatment of severe
This study was performed to evaluate clinical and radiographic outcomes of Hip Resurfacing Arthroplasty for treatment of haemophilic hip arthropathy. Between 2002 and 2013, 17 cases of hip resurfacing arthroplasties were performed in 16 haemophilic patients (13 cases of haemophilia A, 2 cases of haemophilia B, 2 cases of von Willebrand disease). The average age of the patients was 32.5(range: 18∼52) years. The average follow up period from the operation was 6.3 (range: 2∼13) years. In this study, the subjects that completed follow-up were composed of 5 cases composed of patients who were treated with Conserve plus® hip resurfacing system, 5 cases composed of patients who were treated with Durom® hip resurfacing system, 4 cases who were treated with ASR® hip resurfacing system, and 3 cases who were treated with Birmingham® hip resurfacing system. The Modified Harris hip score, the range of motion of the hip joint, perioperative coagulation factor requirements and complications associated with bleeding were evaluated as part of the clinical assessment. For the radiographic assessment, fixation of component, presence of femoral neck fracture, osteolysis, loosening and other complications were evaluated.Purpose
Material & Method
Although total knee arthroplasty (TKA) in end-stage hemophilic arthropathy can reduce the severe joint pain and improve the functional disability, it is technically demanding. In addition, it has generally reported a high rate of complication including periprosthetic joint infection (PJI) and component loosening up to 20%. Although the Knee Society classification system of TKA complication was introduced, the complications of TKA in hemophilic arthropathy has not stratified using this classification system in previous articles to the best of our knowledge. The purpose of this study was to evaluate the mid-term outcomes and complications of TKA in hemophilic arthropathy. The study retrospectively reviewed 131 consecutive primary TKAs (102 patients) in single institute. The mean patient age was 41.0 years and mean follow-up time was 6.4 years. The clinical and radiographic results were evaluated. The complications were categorized according to the classification system of the Knee Society for TKA complications.Introduction
Methods
This is a non controlled experimental prospective4 clinical study that obtained satisfactory results in the chemical Synovectomy with Oxitetracycline Clorhydrate (Emicine), in dfferent joints, demonstrating that it is an Effective method in the treatment of recurrent haemarthrosis in haemophilia.
Besides the experimental demonstration of its action in rabbits is exposed.
The surgical treatment of a secondary gonarthrosis caused by
Purpose. To evaluate the radiological changes after metal on metal resurfacing arthroplasty. Materials and Methods. Between December 1998 and August 2004, 166 hips in 150 patients who underwent metal resurfacing arthroplasty and followed up more than 4 years. Their mean age at the time of operation was 37.3 years(range, 15–68 years) and mean period of follow-up was 6.1 years(range, 48–95 months). The cause of arthroplasty included 115 avascular necrosis, 43 osteoarthritis, 7 ankylosing spondylitis, 1
The history of synoviorthesis in haemophiliacs and recent studies has shown that it is a safe procedure and that the results are similar to those seen following open or arthroscopic synovectomy. Colloidal Yt 90 silicate is a beta emitter with a half life of 2.7 days and a mean depth of penetrating soft tissue of 4mm. We evaluate the outcome of Yt 90 injection in patients with chronic haemophilic synovitis of the knee. A retrospective study was done from 1998–2006 of 35 patients with 44 joint injections. Indications were repeated bleeds (4 episodes); chronic synovitis. The age range was 4–27 years. A dose of 2–5 mCu was injected intra-articularly using a sterile technique and local anaesthetic, after an intravenous factor V111 infusion (5 patients had antibodies) and initial joint lavage. The knees were immobilized in above knee backslabs for 2/7. Patient follow up of up to 8 years was conducted. Patients were assessed for pain relief, range of movement, repeated bleeds, cost saving, quality of life and progression to
Background. The quest for the perfectly designed elbow prosthesis continues as instability and loosening remain the foremost reasons for the failure of total elbow replacement (TER). The Discovery® Elbow System (Biomet, UK) (Figure 1), which has been used in UK since 2003, is one of the latest generations of linked prosthesis. This system was designed to decrease polyethylene-bushing wear, improve anatomic stem design, restore elbow joint biomechanics, and produce a hinge that could be easily revised. This report describes the short term outcome of TER using the Discovery® Elbow System. Patients and Methods. A total of 60 TERs including 48 primary and 12 revisions were performed between 2003 and 2008. Patients included 21 males (37%) and 36 females (63%) with a mean age of 63 years. The indications for primary TER were advanced rheumatoid arthritis (n=19), osteoarthritis (n=16), post traumatic osteoarthritis (n=9), acute fractures (n=3), and
Introduction and Objectives: The goal of this study is to present results from a series of arthroplasties performed in our hospital in the past 3 years in terms of pain and mobility. Materials and Methods: In this study, a total of 14 arthroplasties were performed on 12 patients (including 2 revisions). Follow-up was lost on 3 patients. Of the 9 remaining patients, 5 were females and 4 were male. Average age was 59 years (42–75) at time of surgery. Two prosthetic models were used: Coonrad-Morrey in 5 cases (including one revision) and GSB-III in 6 cases (including one revision). The following conditions were treated: 5 cases of post-traumatic arthrosis of the elbow, one